News
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
14 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
14 Mar 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Recap: Spero Therapeutics Q4 Earnings
13 Mar 24
Earnings
Spero Therapeutics Q4 2023 GAAP EPS $0.96 Beats $(0.10) Estimate, Sales $73.524M Beat $18.633M Estimate
13 Mar 24
Earnings, Earnings Beats, News
Earnings Scheduled For March 13, 2024
13 Mar 24
Earnings
Earnings Outlook For Spero Therapeutics
12 Mar 24
Earnings
Spero Therapeutics Announces First Patient, First Visit For Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr In Complicated Urinary Tract Infections; Spero Is Entitled To Receive $95M In Development Milestone Payments From GSK Over 2 Years
2 Jan 24
Biotech, News, General
Press releases
Thinking about buying stock in CXApp, CCSC Technology International, Vroom, Spero Therapeutics, or OptiNose?
14 Mar 24
Small Cap, Opinion, Press Releases
Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update
13 Mar 24
Earnings, Press Releases
Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections
28 Feb 24
Press Releases
Spero Therapeutics to Present at Cowen's 44th Annual Healthcare Conference
26 Feb 24
News, Press Releases
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31 Jan 24
Press Releases
Spero Therapeutics Provides Corporate Update and 2024 Outlook
5 Jan 24
Health Care, Press Releases
Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections
2 Jan 24
Health Care, Press Releases